Correlation Between Abattis Bioceuticals and Nasdaq
Can any of the company-specific risk be diversified away by investing in both Abattis Bioceuticals and Nasdaq at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abattis Bioceuticals and Nasdaq into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abattis Bioceuticals Corp and Nasdaq Inc, you can compare the effects of market volatilities on Abattis Bioceuticals and Nasdaq and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abattis Bioceuticals with a short position of Nasdaq. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abattis Bioceuticals and Nasdaq.
Diversification Opportunities for Abattis Bioceuticals and Nasdaq
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Abattis and Nasdaq is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Abattis Bioceuticals Corp and Nasdaq Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nasdaq Inc and Abattis Bioceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abattis Bioceuticals Corp are associated (or correlated) with Nasdaq. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nasdaq Inc has no effect on the direction of Abattis Bioceuticals i.e., Abattis Bioceuticals and Nasdaq go up and down completely randomly.
Pair Corralation between Abattis Bioceuticals and Nasdaq
If you would invest 5,831 in Nasdaq Inc on September 1, 2024 and sell it today you would earn a total of 2,468 from holding Nasdaq Inc or generate 42.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Abattis Bioceuticals Corp vs. Nasdaq Inc
Performance |
| Timeline |
| Abattis Bioceuticals Corp |
| Nasdaq Inc |
Abattis Bioceuticals and Nasdaq Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Abattis Bioceuticals and Nasdaq
The main advantage of trading using opposite Abattis Bioceuticals and Nasdaq positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abattis Bioceuticals position performs unexpectedly, Nasdaq can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nasdaq will offset losses from the drop in Nasdaq's long position.| Abattis Bioceuticals vs. Brainsway | Abattis Bioceuticals vs. Venus Concept | Abattis Bioceuticals vs. Tactile Systems Technology | Abattis Bioceuticals vs. Icecure Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world |